US$ 23.94
glp 1 drug market Obesity GLP-1 Glucagon-like Peptide 1 (GLP-1) Market
Description
This makes GLP-1 Elevate a more accessible, needle-free option for those looking to avoid invasive treatment
These options can be ineffective at bestand dangerous at worst

Pharmacotherapy of obesity: an update on the available medications and drugs under investigation
Dulaglutide protects mice against diabetic sarcopenia-mediated muscle injury by inhibiting inflammation and regulating the differentiation of myoblasts

Obesity 31 , 111122 (2023)

Therefore, I think this might be the best option for patients experiencing worsening GERD due to GLP-1-induced delayed gastric emptying
